A Study of Obinutuzumab in Combination With High-Dose Methylprednisolone in Chronic Lymphocytic Leukemia Patients
Phase of Trial: Phase I/II
Latest Information Update: 06 Dec 2016
At a glance
- Drugs Obinutuzumab (Primary) ; Methylprednisolone
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
- 06 Dec 2016 Status changed from recruiting to completed.
- 08 Dec 2015 Results (n=34), presented at the 57th Annual Meeting and Exposition of the American Society of Hematology.